Skip to content
Silver Journal

The Zimbabwean Government Declines ‘Unbalanced’ American Health Aid Deal Due to Information Fears

Medical funding illustration
The proposed American funding was aimed at programmes for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has rejected a substantial US healthcare agreement worth 367 million US dollars (£272m) over five years over the United States' request for confidential biological samples.

This move was revealed following a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa believed the agreement was "lopsided".

A government representative later explained that the US was demanding access to biological samples for scientific study and commercial gain while was unwilling to share the benefits from any future vaccines.

"We are forced to start the difficult and regrettable task of scaling back our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy said the United States had provided over $1.9bn for health programmes to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has appealed for continued talks to find a agreement acceptable to all parties so the country's critical HIV programme can proceed.

Wider Implications

This development follows a similar case in neighbouring Kenya, where a court halted a related deal with the US after concerns were filed about the security of citizens' health data.

After resuming office last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

USAID had administered aid for the American government, but Trump claimed its expenditure was "wasteful" and his government was seeking government-to-government deals to boost transparency and responsibility.

Based on statements, 16 African countries have to date agreed to similar agreements, representing more than $18.3bn of fresh investment.

Specifics of the Declined Deal

The funds for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this collaboration could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million currently on antiretroviral therapy via US-supported programmes," the Ambassador said.

However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".

"Our nation was requested to surrender its genetic material and health information indefinitely, with no equivalent promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.

"Put simply, our nation would supply the basic resources for medical research without any assurance that the final treatments would be accessible to our population should a future health crisis arise."

Sovereignty and Global Health

Mangwana further said that the American exit from the global health body and its push of one-on-one deals were upending structures already set up via the global organization.

Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to deal with future pandemics.

"This framework is intended to guarantee that when a nation contributes its information, the benefits – including vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."

Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.

"We are open to continued dialogue with our American counterparts on how subsequent co-operation could be structured in a way that respects the independence and interests of each country."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but recommended that talks should continue since much of the country's Aids initiatives were funded by international support.

"If specific concerns exist, such as those relating to information security or implementation frameworks, these can frequently be resolved through technical clarification and mutually agreed protections," it added.

The halted deal underscores the continuing challenges between receiving crucial international aid and protecting a country's data in an ever more data-driven world.

JW
The writer

Janice Ward

Elena is a freelance writer and content strategist who loves exploring the intersection of technology and everyday life.

Silver Journal

Type to search articles.